Whether and under what conditions FDG-PET might be cost-effective in evaluating solitary pulmonary nodules depicted on lung cancer screening in Japan

Nippon Acta Radiologica

Volumn 63, Issue 8, 2003, Pages 390-398

  Yoshito, Tsushima ^a   Jun, Aoki ^b   Keigo, Endo ^b  

^a Motojima General Hospital   (Japan)

^b GUNMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cost effectiveness; CT; Decision tree analysis; FDG PET; Lung cancer; Screening

Indexed keywords

ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; COST BENEFIT ANALYSIS; ECONOMICS; FEASIBILITY STUDY; HUMAN; JAPAN; LUNG COIN LESION; LUNG TUMOR; MASS SCREENING; SENSITIVITY AND SPECIFICITY;

COIN LESION, PULMONARY; COST-BENEFIT ANALYSIS; FEASIBILITY STUDIES; HUMANS; JAPAN; LUNG NEOPLASMS; MASS SCREENING; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0642365731     PISSN: 00480428     EISSN: 13477951     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Siegelman S, Khouri N, Leo FP, et al: Solitary pulmonary nodules: CT assessment. Radiology 160: 307-312, 1986
2. Proto AV, Thomas SR: Pulmonary nodules studied by computed tomography. Radiology 156: 149-153, 1985
3. Zerhouni EA, Stitik FP, Siegelman SS, et al: CT of the pulmonary nodule: a cooperative study. Radiology 160: 319-327, 1986
4. Gould MK, Maclean CC, Kuschner WG, et al: Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions. JAMA 285: 914-924, 2001
5. Gambhir SS, Shepherd JE, Shah BD, et al: Analytical decision model for the cost-effective management of solitary pulmonary nodules. J Clin Oncol 16: 2113-2125, 1998
6. Dietlein M, Weber K, Gandjour A, et al: Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany. Eur J Nucl Med 27: 1441-1256, 2000
7. Keith CJ, Miles KA, Griffiths MR, et al: Solitary pulmonary nodules: accuracy and cost-effectiveness of sodium iodide FDG-PET using Australian data. Eur J Nucl Med 29: 1016-1023, 2002
8. Tsukada H, Satou T, Iwashima A, et al: Diagnostic accuracy of CT-gulded automated needle biopsy of lung nodules. AJR 175: 239-243, 2000
9. Larscheid RC, Thorpe PE, Scott WJ: Percutaneous transthoracic needle aspiration biopsy. Chest 114: 704-709, 1998
10. Milman N, Faurschou P, Munch EP, et al. Transbronchial lung biopsy through the fibre optic bronchoscope: results and complications in 452 examinations. Respir Med 88: 749-755, 1994
11. Goldberg-Kahn B, Healy JC, Bishop JW: The cost of diagnosis: a comparison of four different strategies In the workup of solitary radiographic lung lesions. Chest 111: 870-876, 1997
12. Middleton M: TreePlan Decision Tree Add-In. http://www.treeplan.com/
13. Clinical Decision Making Calculators. Department of Family and Preventive Medicine, The University of Oklahoma Health Sciences Center. http://www.fammed.ouhsc.edu/robhamm/cdmcalc.htm#Decision
14. Bogot NR, Shaham D: Semi-invasive and invasive procedures for the diagnosis and staging of lung cancer II: bronchoscopic and surgical procedures. Radiol Clin North Am 38: 535-544, 2000
15. Charig MJ, Phillips AJ: CT-guided cutting needle biopsy of lung lesions: safety and efficacy of an out-patient service. Clin Radiol 55: 964-969, 2000
16. Yamagami T, Nakamura T, Iida S, et al: Management of pneumothorax after percutaneous CT-guided lung biopsy. Chest 121: 1159-1164, 2002
17. Li H, Boiselle PM, Shepard JAO, et al: Diagnostic accuracy and safety of CT-guided percutaneous needle aspiration biopsy of the lung: comparison of small and large pulmonary nodules. AJR 167: 105-109, 1996
18. Wallance MJ, Krishnamurthy S, Broemeling LD, et al: CT-guided percutaneous fine-needle aspiration biopsy of small(≦ 1-cm)pulmonary lesions. Radiology 225: 823-828, 2002
19. Gambhir SS, Hoh CK, Phelps ME, et al: Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma. J Nucl Med 37: 1428-1436, 1996
20. Scott WJ, Shepherd J, Gambhir SS: Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: a decision analysis. Ann Thorac Surg 66: 1876-1885, 1998
21. Kosuda S, Ichihara K, Watanabe M, et al: Decision-tree sensitivity analysis for cost-effectiveness of chest 2-fluoro-2-D-[(18)F] fluorodeoxyglucose positron emission tomography in patients with pulmonary nodules (non-small cell lung carcinoma) in Japan. Chest 117: 346-353, 2000
22. Hicks RJ, Kalff V, MacManus MP, et al: (18) F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer. J Nucl Med 42: 1596-1604, 2001
23. Kosuda S, Ichihara K, Watanabe M, et al: Decision-tree sensitivity analysis for cost-effectiveness of whole-body FDG PET in the management of patients with non-small-cell lung carcinoma in Japan. Ann Nucl Med 16: 263-271, 2002